Table 4. AUROC for significant and advance fibrosis.
Significant fibrosis (F≥2) | Advanced fibrosis (F≥3) | ||||
AUROC | 95% CI | AdAUROC | AUROC | 95% CI | |
PEDIATRICS | |||||
TGF-ß1 | 0.549 | 0.339–0.746 | 0.661 | 0.570 | 0.359–0.764 |
TIMP-1 | 0.625 | 0.411–0.809 | 0.737 | 0.800 | 0.593–0.932 |
HA | 0.585 | 0.368–0.780 | 0.697 | 0.562 | 0.347–0.762 |
PIIINP | 0.648 | 0.417–0.836 | 0.760 | 0.694 | 0.464–0.870 |
ADULTS | |||||
TGF-ß1 | 0.792 | 0.567–0.933 | 0.875 | 0.835 | 0.617–0.957 |
TIMP-1 | 0.575 | 0.349–0.780 | 0.658 | 0.553 | 0.329–0.762 |
HA | 0.783 | 0.558–0.928 | 0.866 | 0.929 | 0.736–0.994 |
PIIINP | 0.792 | 0.567–0.933 | 0.875 | 0.894 | 0.689–0.984 |